Ind-Swift Laboratories Q4 Results
- BSE: 532305
- NSE: INDSWFTLAB
- ISIN: INE915B01019
- Sector: Major Drugs
BSE
99.85
-2.00 (-1.96%)
-2.00 (-1.96%)Volume4.51 K
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
98.63-2.02 (-2.01%)
-2.02 (-2.01%)Volume37.50 K
Updated: Mon 25 Nov, 2024 | 15:15:08
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Ind-Swift Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 393.33 | 312.69 | -% | 304.25 | -% |
| Selling/ General/ Admin Expenses Total | 39.25 | 33.22 | -% | 35.59 | -% |
| Depreciation/ Amortization | 12.67 | 15.39 | -% | 9.29 | -% |
| Other Operating Expenses Total | 78.25 | 43.11 | -% | 42.58 | -% |
| Total Operating Expense | 56.72 | 274.31 | -% | 276.50 | -% |
| Operating Income | 336.62 | 38.37 | -% | 27.74 | -% |
| Net Income Before Taxes | 373.34 | 24.35 | -% | 16.13 | -% |
| Net Income | 238.82 | 27.50 | -% | -25.12 | -% |
| Diluted Normalized EPS | -2.11 | 4.65 | -% | -1.32 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST - Markets
02C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read06:59 PM IST - Markets
03Stocks to buy or sell: Dharmesh Shah of ICICI Securities recommends buying L&T, Syngene International on November 25
5 min read10:00 AM IST